Fortitude Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Sell
2,728
-76
-3% -$8.9K 0.13% 142
2026
Q1
$337K Sell
2,804
-699
-20% -$80.7K 0.15% 137
2025
Q4
$369K Buy
3,503
+155
+5% +$14.6K 0.16% 110
2025
Q3
$281K Sell
3,348
-13
-0.4% -$1.07K 0.15% 148
2025
Q2
$266K Sell
3,361
-574
-15% -$45.6K 0.15% 156
2025
Q1
$301K Sell
3,935
-2,474
-39% -$231K 0.22% 110
2024
Q4
$638K Sell
6,409
-74
-1% -$7.63K 0.38% 48
2024
Q3
$736K Hold
6,483
0.46% 42
2024
Q2
$803K Buy
6,483
+488
+8% +$62.9K 0.48% 34
2024
Q1
$791K Sell
5,995
-306
-5% -$37.7K 0.45% 46
2023
Q4
$687K Buy
6,301
+1,352
+27% +$140K 0.42% 46
2023
Q3
$510K Buy
4,949
+563
+13% +$60.7K 0.34% 65
2023
Q2
$506K Buy
4,386
+33
+0.8% +$3.75K 0.37% 60
2023
Q1
$463K Buy
4,353
+19
+0.4% +$2.05K 0.36% 69
2022
Q4
$481K Buy
4,334
+88
+2% +$8.99K 0.41% 65
2022
Q3
$366K Buy
4,246
+65
+2% +$5.8K 0.35% 74
2022
Q2
$381K Buy
4,181
+1
+0% +$89 0.35% 80
2022
Q1
$344K Buy
4,180
+423
+11% +$33.4K 0.18% 101
2021
Q4
$289K Buy
+3,757
New +$299K 0.15% 134

Other funds holding MRK

Fortitude Advisory Group's MRK Position: Q2 2026 in Review

Fortitude Advisory Group reduced its Merck (MRK) stake by 2.7% in Q2 2026, selling an estimated $8.9K and leaving 2,728 shares worth $351K. The position accounts for 0.13% of the portfolio, ranked #142.

Fortitude Advisory Group first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $803K in Q2 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fortitude Advisory Group held 2,728 shares of Merck worth $351K as of Q2 2026.
  • Fortitude Advisory Group sold 76 Merck shares in Q2 2026, an estimated $8.9K.
  • Merck made up 0.13% of Fortitude Advisory Group's portfolio in Q2 2026, its #142 holding.
  • Fortitude Advisory Group first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Fortitude Advisory Group's Merck position peaked at $803K in Q2 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fortitude Advisory Group's 13F filing for Q2 2026, filed 22 Jul 2026.